Comparing the Effectiveness of Metformin with Lifestyle Modification for the Primary Prevention of Type II Diabetes: a Systematic Review and Meta-analysis

Overview

Journal BMC Endocr Disord

Publisher Biomed Central

Specialty Endocrinology

Date 2023 Sep 18

PMID 37723440

Authors

Sayedah Sarah Mousavi

Seyedeh Mahdieh Namayandeh

Hossein Fallahzadeh

Masoud Rahmanian

Mehdi Mollahosseini

Affiliations

Soon will be listed here.

Abstract

Background: Concerning ascending trend in the prevalence of chronic type II diabetes, prevention and the development of an effective approach after the recognition of at-risk individuals is crucial. This study aims to investigate comparing the influence of lifestyle modification and metformin interventions in the prevention of type II diabetes developments.

Method: The search was conducted using PubMed, Google Scholar, Scopus and Web of Science databases. The inclusion criteria include randomized controlled trials (RCT) which studied both lifestyle modification and metformin interventions in the population above 18 years old without a history of any type of diabetes. After excluding studies with intervention time of fewer than 6 months, a systematic review and meta-analysis were performed to evaluate relative risk (RR) with a confidence interval (CI) of 95% of type II diabetes development.

Results: Data from 5 studies were included in the meta-analysis. The population also consists of individuals with a mean age of 50 years old with BMI and FBS of 35.5 and 104.7 mg/dl respectively. Participants range of prevention years was between 2-3 years with a mean of 2.8 years. Lifestyle modification decreases the probability of the incidence of type II diabetes by 25.3% (RR: 0.747, 95% CI, 0.6-0.92) compared to the metformin intervention (p-value = 0.007). Our results indicate that long-term lifestyle modifications can prevent diabetes type II and decrease diabetes mellitus incidence down to one-quarter in comparison to metformin.

Conclusion: Lifestyle modification can be more efficacious than metformin in diminishing the incidence of type II diabetes. Therefore, lifestyle modification can be a therapeutic strategy for controlling type II diabetes incidence, especially in high-risk individuals.

Citing Articles

Comparing the effectiveness of metformin with lifestyle modification for the primary prevention of type II diabetes: a systematic review and meta-analysis.

Mousavi S, Namayandeh S, Fallahzadeh H, Rahmanian M, Mollahosseini M BMC Endocr Disord. 2023; 23(1):198.

PMID: 37723440 PMC: 10506297. DOI: 10.1186/s12902-023-01445-9.

References

. Latest figures show 463 million people now living with diabetes worldwide as numbers continue to rise. Diabetes Res Clin Pract. 2019; 157:107932. DOI: 10.1016/j.diabres.2019.107932. View

Andreadis E, Katsanou P, Georgiopoulos D, Tsourous G, Yfanti G, Gouveri E . The effect of metformin on the incidence of type 2 diabetes mellitus and cardiovascular disease risk factors in overweight and obese subjects--the Carmos study. Exp Clin Endocrinol Diabetes. 2008; 117(4):175-80. DOI: 10.1055/s-0028-1087177. View

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

OBrien M, Perez A, Scanlan A, Alos V, Whitaker R, Foster G . PREVENT-DM Comparative Effectiveness Trial of Lifestyle Intervention and Metformin. Am J Prev Med. 2017; 52(6):788-797. PMC: 5438762. DOI: 10.1016/j.amepre.2017.01.008. View

Knowler W, Barrett-Connor E, Fowler S, Hamman R, Lachin J, Walker E . Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002; 346(6):393-403. PMC: 1370926. DOI: 10.1056/NEJMoa012512. View

Yamaoka K, Nemoto A, Tango T . Comparison of the Effectiveness of Lifestyle Modification with Other Treatments on the Incidence of Type 2 Diabetes in People at High Risk: A Network Meta-Analysis. Nutrients. 2019; 11(6). PMC: 6627198. DOI: 10.3390/nu11061373. View

Hostalek U, Gwilt M, Hildemann S . Therapeutic Use of Metformin in Prediabetes and Diabetes Prevention. Drugs. 2015; 75(10):1071-94. PMC: 4498279. DOI: 10.1007/s40265-015-0416-8. View

. Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study. Lancet Diabetes Endocrinol. 2015; 3(11):866-75. PMC: 4623946. DOI: 10.1016/S2213-8587(15)00291-0. View

Magliano D, Islam R, Barr E, Gregg E, Pavkov M, Harding J . Trends in incidence of total or type 2 diabetes: systematic review. BMJ. 2019; 366:l5003. PMC: 6737490. DOI: 10.1136/bmj.l5003. View

10.

Higgins J, Thompson S . Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21(11):1539-58. DOI: 10.1002/sim.1186. View

11.

Lu Y, Lu J, Wang S, Li C, Zheng R, Tian H . Outcome of intensive integrated intervention in participants with impaired glucose regulation in China. Adv Ther. 2011; 28(6):511-9. DOI: 10.1007/s12325-011-0022-4. View

12.

Ramachandran A, Snehalatha C, MARY S, Mukesh B, Bhaskar A, Vijay V . The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006; 49(2):289-97. DOI: 10.1007/s00125-005-0097-z. View

13.

Mousavi S, Namayandeh S, Fallahzadeh H, Rahmanian M, Mollahosseini M . Comparing the effectiveness of metformin with lifestyle modification for the primary prevention of type II diabetes: a systematic review and meta-analysis. BMC Endocr Disord. 2023; 23(1):198. PMC: 10506297. DOI: 10.1186/s12902-023-01445-9. View

14.

Lily M, Lilly M, Godwin M . Treating prediabetes with metformin: systematic review and meta-analysis. Can Fam Physician. 2009; 55(4):363-9. PMC: 2669003. View

15.

Haw J, Galaviz K, Straus A, Kowalski A, Magee M, Weber M . Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials. JAMA Intern Med. 2017; 177(12):1808-1817. PMC: 5820728. DOI: 10.1001/jamainternmed.2017.6040. View

16.

Gillies C, Abrams K, Lambert P, Cooper N, Sutton A, Hsu R . Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis. BMJ. 2007; 334(7588):299. PMC: 1796695. DOI: 10.1136/bmj.39063.689375.55. View

17.

Weber M, Ranjani H, Staimez L, Anjana R, Ali M, Narayan K . The Stepwise Approach to Diabetes Prevention: Results From the D-CLIP Randomized Controlled Trial. Diabetes Care. 2016; 39(10):1760-7. PMC: 5033082. DOI: 10.2337/dc16-1241. View